Johnson Mak: We Figure Out How SARS-CoV-2 Induces Thrombosis
Johnson Mak, Professor at Institute for Biomedicine and Glycomics, Griffith University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in bioRxiv, adding:
”Excited to share our latest work by Ablikim Bake et al.
We figure out how SARS-CoV-2 induces thrombosis, and it turns out to be glycan (sialic acid) but NOT protein.
We have used state-of-the-art 3D EM (see movie) to show viral particles are trapped within the invaginated structure in platelets, making platelets as Trojan horse to delay virus clearance in convalescent patients.”
Title: SARS-CoV-2 spike protein-associated sialoglycoconjugates induce nanoscale filipodia to facilitate micro-size platelet clotting
Authors: Ablikim Baqi, Ainur Sanaubarova, Belinda L Spillings, Erwan Bremaud, Veronika Masic, Larissa Dirr, Mark von Itzstein, Johnson Mak
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention